Evidence map›Paper›PMID 33466869›Full record

ArticleInternational journal of molecular sciences2021

Identification of Molecular Basis for Objective Discrimination of Breast Cancer Cells (MCF-7) from Normal Human Mammary Epithelial Cells by Raman Microspectroscopy and Multivariate Curve Resolution Analysis.

Keita Iwasaki, Asuka Araki, C Murali Krishna, Riruke Maruyama, Tatsuyuki Yamamoto, Hemanth Noothalapati

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Keita IwasakiThe United Graduate School of Agricultural Sciences, Tottori University, Tottori 680-8550, Japan.ORCID 0000-0002-3908-2272
Asuka ArakiDepartment of Organ Pathology, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan.ORCID 0000-0002-2185-4828
C Murali KrishnaAdvanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai 410-210, India.
Riruke MaruyamaDepartment of Organ Pathology, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan.
Tatsuyuki YamamotoFaculty of Life and Environmental Science, Shimane University, Matsue 690-8504, Japan.
Hemanth NoothalapatiRaman Project Center for Medical and Biological Applications, Shimane University, Matsue 690-8504, Japan.ORCID 0000-0002-8279-7716
Shimane University · JPTata Memorial Hospital · INTottori University · JP

Funding

JSPS 15H04763Shimane University Collaborated study aiming for the development of new diagnostic techniques by Raman spectroscopy
6 · The paper itself

Abstract

Raman spectroscopy (RS), a non-invasive and label-free method, has been suggested to improve accuracy of cytological and even histopathological diagnosis. To our knowledge, this novel technique tends to be employed without concrete knowledge of molecular changes in cells. Therefore, identification of Raman spectral markers for objective diagnosis is necessary for universal adoption of RS. As a model study, we investigated human mammary epithelial cells (HMEpC) and breast cancer cells (MCF-7) by RS and employed various multivariate analyses (MA) including principal components analysis (PCA), linear discriminant analysis (LDA), and support vector machine (SVM) to estimate diagnostic accuracy. Furthermore, to elucidate the underlying molecular changes in cancer cells, we utilized multivariate curve resolution analysis-alternating least squares (MCR-ALS) with non-negative constraints to extract physically meaningful spectra from complex cellular data. Unsupervised PCA and supervised MA, such as LDA and SVM, classified HMEpC and MCF-7 fairly well with high accuracy but without revealing molecular basis. Employing MCR-ALS analysis we identified five pure biomolecular spectra comprising DNA, proteins and three independent unsaturated lipid components. Relative abundance of lipid 1 seems to be strictly regulated between the two groups of cells and could be the basis for excellent discrimination by chemometrics-assisted RS. It was unambiguously assigned to linoleate rich glyceride and therefore serves as a Raman spectral marker for reliable diagnosis. This study successfully identified Raman spectral markers and demonstrated the potential of RS to become an excellent cytodiagnostic tool that can both accurately and objectively discriminates breast cancer from normal cells.

Indexed as

Biomarkers, TumorBreastBreast NeoplasmsDiscriminant AnalysisEpithelial CellsGlyceridesHumansLeast-Squares AnalysisLinoleic AcidMCF-7 CellsMultivariate AnalysisPrincipal Component AnalysisReproducibility of ResultsSensitivity and SpecificitySpectrum Analysis, RamanSupport Vector MachineBiomarkers, TumorGlyceridesLinoleic Acidbreast cancercancer diagnosischemometricscpectral markercytodiagnosislinoleic acidlipid metabolismMCR-ALSPUFARaman spectroscopy

Identifiers

PMID33466869
PMCPMC7830327
OpenAlexW3120756519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.